I posted something similar a while back suggesting they take a leaf out of CUV's (Clinuvel Pharma's) book by holding road shows with HNW and UHNW individuals and family offices, and offer them private placements at a premium to current share price.
I believe it would add a lot of confidence and help diversify the share register rather than consolidate power in a few funds. Also could be a lot cheaper than engaging a broker/ IB to help with a raise.
Ann: Results Demonstrating Restoration of Normal Pre-Disease Flow, page-14
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.68 |
Change
-0.320(2.67%) |
Mkt cap ! $246.9M | |||
| Open | High | Low | Value | Volume |
| $11.57 | $11.81 | $11.42 | $152.5K | 13.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 116 | $11.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.68 | 188 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |